Effect of Buyang Huanwu Tang on Cerebral Vascular Reserve Function in Patients with Qi Deficiency and Blood Stasis Type Cerebral Infarction

WU Yu-fu; LIU Xiao-hong; GUO Wei-cheng; ZHAO Jie; WANG Hao-ran; HE Fei-fei

doi:10.13422/j.cnki.syfjx.2017120162

您当前的位置：

首页 >

文章列表页 >

Effect of Buyang Huanwu Tang on Cerebral Vascular Reserve Function in Patients with Qi Deficiency and Blood Stasis Type Cerebral Infarction

更新时间：2024-01-04

- Effect of Buyang Huanwu Tang on Cerebral Vascular Reserve Function in Patients with Qi Deficiency and Blood Stasis Type Cerebral Infarction
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 23, Issue 12, Pages: 162-167(2017)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2017120162
  CLC： R277.7
- Published：2017
- 稿件说明：
移动端阅览
WU Yu-fu, LIU Xiao-hong, GUO Wei-cheng, et al. Effect of Buyang Huanwu Tang on Cerebral Vascular Reserve Function in Patients with Qi Deficiency and Blood Stasis Type Cerebral Infarction[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(12): 162-167.
DOI：

WU Yu-fu, LIU Xiao-hong, GUO Wei-cheng, et al. Effect of Buyang Huanwu Tang on Cerebral Vascular Reserve Function in Patients with Qi Deficiency and Blood Stasis Type Cerebral Infarction[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(12): 162-167. DOI： 10.13422/j.cnki.syfjx.2017120162.

摘要

目的：采用经颅多普勒（TCD）结合屏气试验评价补阳还五汤对气虚血瘀型脑梗死患者脑血管储备功能的影响，并观察两组临床疗效和神经功能缺损评分。方法：将150例气虚血瘀型脑梗死患者随机分为2组，治疗组78例；对照组72例。两组均给予西医规范治疗，口服阿司匹林肠溶片，100 mg/次，1次/d，或口服硫酸氢氯吡格雷片，75 mg/次，1次/d；根据病情给予脱水降颅压，脑细胞保护药物，他汀类降脂治疗，调控血压、血糖及康复治疗。对照组在西医规范治疗基础上加三七通舒胶囊，0.2 g/次，3次/d。治疗组在西医规范治疗的基础上加用补阳还五汤，180 mL/次，2次/d。通过TCD结合屏气试验测定治疗前后脑血管储备功能（CVR），屏气指数（BMI）和平均血流速度（Vm）上升率。并观察两组临床疗效和神经功能缺损（NIHSS）评分。结果：治疗组总有效率达到91%，对照组总有效率76.4%，治疗组优于对照组（P<0.05）。与治疗前比较，治疗后7，14 d治疗组NIHSS评分明显降低（P<0.05），治疗组低于对照组（P<0.05）。与治疗前比较，治疗后14 d治疗组CVR，BMI，Vm上升率均明显提高（P<0.05）；治疗后14 d，治疗组CVR高于对照组（P<0.05）。结论：在西医常规治疗的基础上，补阳还五汤能改善气虚血瘀型脑梗死患者的脑血管储备功能，改善神经功能缺损，提高临床疗效。

Abstract

Objective: To explore the effect of Buyang Huanwu Tang on cerebral vascular reserve function in patients with Qi deficiency and blood stasis type cerebral infarction by using transcranial Doppler (TCD) combined with breath holding test

and to observe the clinical efficacy and neurological deficit scores in two groups. Method: The 150 patients with Qi deficiency and blood stasis type cerebral infarction were randomly divided into 2 groups:the treatment group of 78 cases and the control group of 72 cases. Patients in both groups received standardized western medicine treatment:aspirin enteric-coated tablets

100 mg/times

1 time/day; or Clopidogrel Bisulfate tablets

75 mg/times

1 time/day; medicines for reducing intracranial pressure

brain protective drugs

statin lipid-lowering therapy or rehabilitation therapy was given to regulate blood pressure and blood sugar according to actual conditions. Based on the western medicine treatment

patients in control group added Sanqi Tongshu capsules

0.2 g/times

3 times/day

but the patients in treatment group added Buyang Huanwu Tang on the basis of western medicine treatment

180 mL/time

2 times/day. Before and after treatment

TCD combined with breath holding test was used to determine the cerebral vascular reserve (CVR)

breath holding index (BMI) and mean velocity (Vm) rate; in addition

the clinical efficacy and NIHSS scores were observed in both groups. Result: The total effective rate was 91% in treatment group

better than 76.4% in control group (P<0.05). Day 7 and day 14 after treatment

the NIHSS scores in treatment group were significantly reduced (P<0.05)

and they were lower than those in control group (P<0.05). On day 14 after treatment

the levels of CVR

BMI and Vm were increased in treatment group (P<0.05)

and the level of CVR in treatment group was higher than that in conrol group (P<0.05). Conclusion: On the basis of routine treatment of Western medicine

Buyang Huanwu Tang can improve the cerebral vascular reserve function in patients with Qi deficiency and blood stasis type cerebral infarction

so as to improve neurological function and improve clinical efficacy.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy of Zhuyuwan in Treatment of Hyperlipidemia with Syndrome of Phlegm Turbidity and Obstruction

Establishment and Evaluation of Mouse Model of Cerebral Infarction with Qi and Yin Deficiency Syndrome Based on Metabolomics

Clinical Randomized Controlled Trial of Traditional Chinese Medicine Compound Shenlong Decoction Granules in Treatment of Idiopathic Pulmonary Fibrosis

Clinical Efficacy of Jinwei Pingchuan Decoction in Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Phlegm-heat Obstruction in Lung Syndrome

Clinical Efficacy of Fuyuan Tongluo Prescription in Prevention and Treatment of Restenosis with Collateral Obstruction Syndrome After Interventional Operation of Lower Limb Arteriosclerosis Obliterans

Related Author

YANG Lele

LUO Danmei

CHEN Jiao

ZHANG Xiaobo

SONG Wei

ZHU Wenyu

ZHOU Xin

LI Xueping

Related Institution

Hospital of Chengdu University of Traditional Chinese Medicine （TCM）

Chengdu University of TCM

Beijing Key Laboratory of Chinese Materia Pharmacology，National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases，Institute of Basic Medical Sciences， Xiyuan Hospital，China Academy of Chinese Medical Sciences

Natural History Museum of China

Liaoning University of Traditional Chinese Medicine（TCM）

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰